Mark Shearman
Chief Executive Officer presso Aprinoia Therapeutics, Inc. /US/
Posizioni attive di Mark Shearman
Società | Posizione | Inizio | Fine |
---|---|---|---|
Aprinoia Therapeutics, Inc. /US/
Aprinoia Therapeutics, Inc. /US/ BiotechnologyHealth Technology Aprinoia Therapeutics, Inc. operates as a global clinical-stage biopharmaceutical company. It develops imaging diagnostic tools, targeted therapy drugs, and other products. The company was founded in 2015 and is headquartered in Cambridge, MA. | Director/Board Member | 10/10/2023 | - |
Chief Executive Officer | 14/07/2023 | - |
Storia della carriera di Mark Shearman
Precedenti posizioni note di Mark Shearman
Società | Posizione | Inizio | Fine |
---|---|---|---|
APPLIED GENETIC TECHNOLOGIES CORPORATION | Chief Tech/Sci/R&D Officer | 01/06/2015 | 20/04/2021 |
MERCK KGAA | Corporate Officer/Principal | 01/01/2009 | 01/01/2015 |
Merck Research Laboratories Massachusetts LLC
Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The private company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life. | Director/Board Member | 01/01/2006 | 01/07/2009 |
MERCK & CO., INC. | Corporate Officer/Principal | 01/01/2006 | 01/01/2009 |
Merck Sharp & Dohme Research Laboratories Neuroscience Researc | Corporate Officer/Principal | 01/01/1992 | 01/01/2005 |
EDITAS MEDICINE, INC. | Chief Tech/Sci/R&D Officer | 01/06/2021 | 31/03/2023 |
Corporate Officer/Principal | 31/03/2023 | - | |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Corporate Officer/Principal | - | - |
Formazione di Mark Shearman
University of Bristol | Undergraduate Degree |
The University of Nottingham | Doctorate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 7 |
Regno Unito | 4 |
Germania | 2 |
Posizioni
Corporate Officer/Principal | 5 |
Chief Tech/Sci/R&D Officer | 2 |
Director/Board Member | 2 |
Settori
Health Technology | 8 |
Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 3 |
---|---|
MERCK & CO., INC. | Health Technology |
MERCK KGAA | Health Technology |
EDITAS MEDICINE, INC. | Health Technology |
Aziende private | 5 |
---|---|
Beacon Therapeutics (USA), Inc.
Beacon Therapeutics (USA), Inc. Pharmaceuticals: GenericHealth Technology Applied Genetic Technologies Corp. is a clinical stage biotechnology company, which engages in the usage of a gene therapy platform to develop transformational genetic therapies for patients suffering from rare and debilitating diseases. The firm also focuses on conducting clinical trials in the field of ophthalmology, optogenetics, adrenoleukodystrophy, and otology. The company was founded by Richard Jude Samulski, Nicholas Muzyczka, William W. Hauswirth, Terence R. Flotte, and Barry J. Byrne on January 19, 1999 and is headquartered in Alachua, FL. | Health Technology |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Health Technology |
Merck Research Laboratories Massachusetts LLC
Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The private company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life. | Health Technology |
Merck Sharp & Dohme Research Laboratories Neuroscience Researc | |
Aprinoia Therapeutics, Inc. /US/
Aprinoia Therapeutics, Inc. /US/ BiotechnologyHealth Technology Aprinoia Therapeutics, Inc. operates as a global clinical-stage biopharmaceutical company. It develops imaging diagnostic tools, targeted therapy drugs, and other products. The company was founded in 2015 and is headquartered in Cambridge, MA. | Health Technology |
- Borsa valori
- Insiders
- Mark Shearman
- Esperienza